← Back to Screener
Henry Schein Inc (HSIC)
Price$76.40
Value ScoreC
Growth ScoreC
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-8.34%
Price vs S&P 500 (4W)-1.39%
VGM Score48.31
Market Capitalization$8.70B
P/E Ratio (Annual)21.85x
All Metrics
P/CF (Annual)12.21x
Book Value / Share (Quarterly)$28.54
P/TBV (Annual)4.04x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)1.40%
Cash Flow / Share (Quarterly)$3.42
Price vs S&P 500 (YTD)-9.61%
Gross Margin (TTM)31.19%
Net Profit Margin (TTM)2.95%
EPS (TTM)$3.31
10-Day Avg Trading Volume1.59M
EPS Excl Extra (TTM)$3.31
Revenue Growth (5Y)5.43%
EPS (Annual)$3.27
ROI (Annual)6.27%
Gross Margin (Annual)31.14%
Net Profit Margin (5Y Avg)3.76%
Cash / Share (Quarterly)$1.21
P/E Basic Excl Extra (TTM)22.01x
Revenue Growth QoQ (YoY)6.31%
EPS Growth (5Y)2.97%
P/E Normalized (Annual)21.85x
ROA (Last FY)3.55%
Revenue Growth TTM (YoY)5.64%
EBITD / Share (TTM)$7.76
ROE (5Y Avg)13.83%
Operating Margin (TTM)4.93%
Cash Flow / Share (Annual)$4.50
P/B Ratio2.66x
P/B Ratio (Quarterly)2.55x
Net Income / Employee (Annual)$15,900
EV / Revenue (TTM)0.89x
Net Interest Coverage (TTM)5.56x
ROA (TTM)3.55%
EPS Growth QoQ (YoY)4.63%
EV / EBITDA (TTM)12.89x
EPS Incl Extra (Annual)$3.27
Current Ratio (Annual)1.38x
Quick Ratio (Quarterly)0.56x
3-Month Avg Trading Volume1.41M
52-Week Price Return6.39%
EV / Free Cash Flow (Annual)22.97x
P/E Incl Extra (TTM)22.01x
Revenue / Employee (TTM)$535,400
Tangible BV / Share (Quarterly)$19.74
P/S Ratio (Annual)0.66x
Asset Turnover (Annual)1.18x
52-Week High$89.29
Operating Margin (5Y Avg)5.52%
EPS Excl Extra (Annual)$3.27
CapEx CAGR (5Y)31.38%
Tangible BV CAGR (5Y)-4.94%
26-Week Price Return7.59%
Quick Ratio (Annual)0.56x
13-Week Price Return-6.00%
Total Debt / Equity (Annual)0.96x
Current Ratio (Quarterly)1.36x
Enterprise Value$11.97B
Revenue / Share Growth (5Y)8.89%
Asset Turnover (TTM)1.20x
Book Value / Share Growth (5Y)3.59%
Revenue / Employee (Annual)$527,400
Inventory Turnover (Annual)4.76x
Pretax Margin (Annual)4.04%
Cash / Share (Annual)$1.35
3-Month Return Std Dev24.50%
Gross Margin (5Y Avg)30.80%
Net Income / Employee (TTM)$15,800
EBITDA CAGR (5Y)5.60%
EBITDA Interim CAGR (5Y)-2.27%
ROE (Last FY)12.27%
Net Interest Coverage (Annual)5.48x
EPS Basic Excl Extra (Annual)$3.27
P/FCF (TTM)16.50x
Receivables Turnover (TTM)8.12x
EV / Free Cash Flow (TTM)30.60x
Total Debt / Equity (Quarterly)1.04x
EPS Incl Extra (TTM)$3.31
Receivables Turnover (Annual)8.42x
ROI (TTM)6.09%
P/S Ratio (TTM)0.65x
Pretax Margin (5Y Avg)4.98%
Revenue / Share (Annual)$108.32
Tangible BV / Share (Annual)$19.24
Forward P/E13.76x
Free OCF CAGR (5Y)-1.08%
Price vs S&P 500 (52W)-21.82%
P/E Ratio (TTM)22.01x
EPS Growth TTM (YoY)2.93%
Year-to-Date Return1.32%
5-Day Price Return3.19%
EPS Normalized (Annual)$3.27
ROA (5Y Avg)5.00%
Net Profit Margin (Annual)3.02%
Month-to-Date Return2.67%
Cash Flow / Share (TTM)$5.11
EBITD / Share (Annual)$7.77
EPS Growth (3Y)-5.69%
Operating Margin (Annual)4.95%
LT Debt / Equity (Annual)0.71x
P/CF (TTM)15.04x
ROI (5Y Avg)9.23%
P/E Excl Extra (TTM)22.01x
LT Debt / Equity (Quarterly)0.71x
EPS Basic Excl Extra (TTM)$3.31
P/TBV (Quarterly)3.69x
P/B Ratio (Annual)2.77x
Inventory Turnover (TTM)4.78x
Pretax Margin (TTM)4.02%
Book Value / Share (Annual)$28.03
Price vs S&P 500 (13W)-15.75%
Net Margin Growth (5Y)-5.42%
Beta0.83x
P/FCF (Annual)16.69x
Revenue / Share (TTM)$115.32
ROE (TTM)11.86%
52-Week Low$61.95
vGradeC
gGradeC
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 261.32est. 1.24
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
3.70
3.77
3.79
3.79
Industry Peers — Medical & Hospital Equipment(1)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
HSICHenry Schein Inc | C | C | C | $76.40 |
| ACHAccendra Health, Inc. | A | F | C | $2.77 |
About
Henry Schein is a healthcare solutions provider offering equipment, products, and services to dental and medical practitioners. The company generates primary revenue through Global Distribution and Value-Added Services, which supplies branded merchandise, equipment, and ancillary services including financial solutions and continuing education. Complementary revenues stem from Global Specialty Products and Global Technology segments serving both office-based and alternative care sites.